Terrorists and the Potential Use of Biological Weapons
A Discussion of Possibilities
ResearchPublished 1989
A Discussion of Possibilities
ResearchPublished 1989
This report considers the potential for terrorists to use biological weapons. It discusses the implications of recent trends in terrorism for the future use of biological agents and the reasons terrorists might be motivated to use them. It then identifies several constraints that inhibit terrorists from venturing into this new type of conflict and the factors that could break down these constraints. Finally, it establishes some broad characteristics that could identify the types of terrorist groups that might be more likely than others to use biological weapons. The findings suggest that, since the technological, logistical, and financial barriers to the use of biological agents are not insurmountable, a key determinant in the potential use of such agents will be the willingness of terrorists to engage in this new type of violence. Therefore, efforts to improve intelligence regarding terrorist group strategies and capabilities will become increasingly critical in the future.
This publication is part of the RAND report series. The report series, a product of RAND from 1948 to 1993, represented the principal publication documenting and transmitting RAND's major research findings and final research.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.